Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Multicenter, Randomized, Controlled, Double-Masked Clinical Trial to Evaluate the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease (The ONSET-1 Study)

Next Previous
Trial Profile

Multicenter, Randomized, Controlled, Double-Masked Clinical Trial to Evaluate the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease (The ONSET-1 Study)

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 14 Mar 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Varenicline (Primary)
  • Indications Dry eyes
  • Focus Registrational; Therapeutic Use
  • Acronyms ONSET; ONSET-1
  • Sponsors Oyster Point Pharmaceuticals

    • Most Recent Events

    • 01 Feb 2023 Results of an analysis of integrated data (n=602) assessing efficacy outcomes for VNS in patients with mild-moderate and severe dry eye disease from two randomized clinical trials (ONSET-1; NCT03636061) and (ONSET-2; NCT04036292), published in the Optometry and Vision Science.
    • 18 Nov 2022 Results of post hoc subgroup analysis of data integrated from ONSET-1 and ONSET-2, published in the Ophthalmology and Therapy
    • 01 Oct 2022 Primary endpoint (Schirmers Test /Eye Dryness Score (Visual Analogue Scale (VAS)) has been met according to results published in the Cornea
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top